Pages that link to "Item:Q87467"
From MaRDI portal
The following pages link to Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points (Q87467):
Displaying 39 items.
- surrosurv (Q30016) (← links)
- Assessing the value of a censored surrogate outcome (Q118842) (← links)
- Missing data methods in longitudinal studies: a review (Q619079) (← links)
- On composite marginal likelihoods (Q732228) (← links)
- An information-theoretic approach to surrogate-marker evaluation with failure time endpoints (Q746103) (← links)
- Choice of units of analysis and modeling strategies in multilevel hierarchical models (Q957034) (← links)
- Exploring and validating surrogate endpoints in colorectal cancer (Q1029801) (← links)
- Center-within-trial versus trial-level evaluation of surrogate endpoints (Q1623614) (← links)
- Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials (Q1658329) (← links)
- Assessing the numerical integration of dynamic prediction formulas using the exact expressions under the joint frailty-copula model (Q2068976) (← links)
- Bayesian ridge estimators based on copula-based joint prior distributions for regression coefficients (Q2095777) (← links)
- Meta-analysis of individual patient data with semi-competing risks under the Weibull joint frailty-copula model (Q2228211) (← links)
- Simplified modeling strategies for surrogate validation with multivariate failure-time data (Q2445595) (← links)
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials (Q2475730) (← links)
- Statistical evaluation of surrogate endpoints with examples from cancer clinical trials (Q2792764) (← links)
- Multivariate frailty models for two types of recurrent events with a dependent terminal event: Application to breast cancer data (Q2857993) (← links)
- Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling (Q2894010) (← links)
- Bayesian Adaptive Trial Design for a Newly Validated Surrogate Endpoint (Q2894012) (← links)
- Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling (Q3119801) (← links)
- Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach (Q3445321) (← links)
- On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm (Q3637000) (← links)
- True endpoint reduction by surrogate endpoints (Q4638854) (← links)
- Generalized shared-parameter models and missingness at random (Q5194716) (← links)
- Unbalanced cluster sizes and rates of convergence in mixed-effects models for clustered data (Q5222463) (← links)
- Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data (Q5450466) (← links)
- Pairwise Fitting of Mixed Models for the Joint Modeling of Multivariate Longitudinal Profiles (Q5492080) (← links)
- Estimation of a common mean vector in bivariate meta-analysis under the FGM copula (Q5742600) (← links)
- Confirmatory adaptive group sequential designs for single‐arm phase II studies with multiple time‐to‐event endpoints (Q6068471) (← links)
- A joint frailty‐copula model for meta‐analytic validation of failure time surrogate endpoints in clinical trials (Q6071311) (← links)
- Testing for Heterogeneity in the Utility of a Surrogate Marker (Q6079768) (← links)
- Cluster-robust estimators for multivariate mixed-effects meta-regression (Q6111506) (← links)
- Bayesian ridge regression for survival data based on a vine copula-based prior (Q6120619) (← links)
- One-step validation method for surrogate endpoints using data from multiple randomized cancer clinical trials with failure-time endpoints (Q6624663) (← links)
- Bivariate network meta-analysis for surrogate endpoint evaluation (Q6624702) (← links)
- Quantifying the association between progression-free survival and overall survival in oncology trials using Kendall's \(\tau\) (Q6625675) (← links)
- Optimizing and evaluating biomarker combinations as trial-level general surrogates (Q6625926) (← links)
- Multi-stage enrichment and basket trial designs with population selection (Q6627189) (← links)
- Estimation of treatment effect in 2-in-1 adaptive design and some of its extensions (Q6627812) (← links)
- Joint modeling of progression-free and overall survival and computation of correlation measures (Q6628690) (← links)
